Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2011
Total Assets: $1.32B
Liabilities Breakdown FY2011
Total Liabilities: $837.9M
Asset Breakdown
Total Assets: $1.32B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $483.6M | 36.5% |
| Accounts Receivable | $28.3M | 2.1% |
| Inventory | $16.6M | 1.3% |
| Property, Plant & Equipment | $368.0M | 27.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $427.2M | 32.3% |
Liabilities Breakdown
Total Liabilities: $837.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $27.7M | 3.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $810.1M | 96.7% |